Download presentation
Presentation is loading. Please wait.
Published byBirthe Bagge Modified over 5 years ago
1
Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention
4
Rethinking Our Thinking About HPV
5
Recommendations for Routine Vaccination With the HPV Vaccine
6
Expanded Use of 9vHPV Vaccine
7
Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention
8
Do Women Remain at Risk for Acquiring HPV Infection Throughout Their Lifetime?
9
The Risk in Women for Acquiring HPV Infection Never Goes Away
10
HPV Infection Is Common in Adults
11
FUTURE III: Mid-Adult Women Trial Efficacy of q4HPV Vaccine in Adult Women Age 24 to 45 Years
12
FUTURE III: Mid-Adult Women Trial Long-Term Extension Trial
13
Efficacy of HPV Vaccination In Persons With a History of HPV-Related Disease: Women
14
Efficacy of HPV Vaccination In Persons With a History of HPV-Related Disease: Men
15
HPV Infection Is a Life-Course Infection
16
Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention
17
Burden of HPV-Related Disease in Men
18
HPV Infection Is a Necessary Precursor to HPV Disease in Men
19
Prevalence of HPV Infection Varies Across Geographic Sites in Men
20
HPV Disease in Men Compared With HPV Disease in Women
21
HPV Infection in Men: Age and Anatomic Site
22
Oral HPV Infection Prevalence Differs by Country and Age Group in Men
23
HPV Is a Man's Problem
24
High Burden of Genital Warts in Men Across the Lifespan
25
No Breakthrough Genital Infection or Disease in Long-Term Follow-Up of Vaccinated Males
26
What's Different in Men
27
Trends in Oral HPV in Men
28
Rethinking Our Thinking About HPV
29
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.